BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients. Read the Press Release Partager cet article Share on LinkedInShare on LinkedIn Share on XShare on X Share on FacebookShare on Facebook Pin itShare on Pinterest Share on WhatsAppShare on WhatsApp Post navigationPreviousPrevious post:November 15, 2016NextNext post:November 28, 2016